Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Non-comparable and Open Clinical Research to Evaluate Long-term Immunity by Neutralizing Antibody Test of Adults in High Risk Population of HFRS (Hemorrhagic Fever With Renal Syndrome) After Vaccination and Booster Vaccination of Hantavax

NCT02360514 is registered in ClinicalTrials.gov with Green Cross Corporation as lead sponsor.

NCT NCT02360514
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02360514 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Non-comparable and Open Clinical Research to Evaluate Long-term Immunity by Neutralizing Antibody Test of Adults in High Risk Population of HFRS (Hemorrhagic Fever With Renal Syndrome) After Vaccination and Booster Vaccination of Hantavax
Lead sponsor
Green Cross Corporation
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2007
Completion date
October 31, 2012
Enrollment
226 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

infection